Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
Schab A, Compadre A, Drexler R, Loeb M, Rodriguez K, Brill J, Harrington S, Sandoval C, Sanders B, Kuroki L, McCourt C, Hagemann AR, Thaker P, Mutch D, Powell M, Serra V, Hagemann IS, Walts AE, Karlan BY, Orsulic S, Fuh K, Sun L, Verma P, Lomonosova E, Zhao P, Khabele D, Mullen M.
Schab A, et al. Among authors: mccourt c.
bioRxiv [Preprint]. 2024 Nov 25:2024.11.21.624682. doi: 10.1101/2024.11.21.624682.
bioRxiv. 2024.
PMID: 39651311
Free PMC article.
Preprint.